Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Change in Inventory: 2019-2024

Historic Change in Inventory for GeneDx Holdings (WGS) over the last 6 years, with Dec 2024 value amounting to $2.6 million.

  • GeneDx Holdings' Change in Inventory fell 379.25% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $526,000, marking a year-over-year decrease of 71.38%. This contributed to the annual value of $2.6 million for FY2024, which is 365.13% up from last year.
  • Per GeneDx Holdings' latest filing, its Change in Inventory stood at $2.6 million for FY2024, which was up 365.13% from -$975,000 recorded in FY2023.
  • In the past 5 years, GeneDx Holdings' Change in Inventory ranged from a high of $10.6 million in FY2021 and a low of -$2.4 million during FY2022.
  • Its 3-year average for Change in Inventory is -$246,667, with a median of -$975,000 in 2023.
  • As far as peak fluctuations go, GeneDx Holdings' Change in Inventory plummeted by 122.12% in 2022, and later skyrocketed by 365.13% in 2024.
  • Over the past 5 years, GeneDx Holdings' Change in Inventory (Yearly) stood at $9.0 million in 2020, then grew by 18.32% to $10.6 million in 2021, then plummeted by 122.12% to -$2.4 million in 2022, then surged by 58.51% to -$975,000 in 2023, then soared by 365.13% to $2.6 million in 2024.